Whalesbook: AI-Powered Stock Updates via WhatsApp

Stock Analysis

Description

Narayana Hrudayalaya Ltd is engaged in providing economical healthcare services. It has a network of multispecialty and super specialty hospitals spread across multiple locations.

Key Growth Triggers

The incorporation of 'Narayana Healthcare North Private Limited' signifies a strategic move to establish a focused entity for the Northern Indian region, aiming to optimize presence and capitalize on market potential, which could drive future growth in that geographical segment.

Order Book

Currently no data available for Order Book.

Key Red Flags

Currently no data available for Key Red Flags.

Key Dates To Watch

Currently no data available for Key Dates To Watch.

Corporate Announcements

2nd Apr 26

Impact Rating: 8

Narayana Hrudayalaya Limited convened meetings on April 2, 2026, where shareholders, secured creditors, and unsecured creditors voted on a proposed scheme of arrangement with NH Integrated Care Private Limited.

27th Mar 26

Impact Rating: 6

Narayana Health clarified news about its Katra hospital, confirming the Business Transfer Agreement with Shri Mata Vaishno Devi Charitable Society is an implementation of a previously disclosed arrangement, not a new material event.

25th Mar 26

Impact Rating: 5

Narayana Hrudayalaya informed about a physical group investor meeting on March 27, 2026, at 10:30 AM IST, with Premji, Magma & Arohi.

25th Mar 26

Impact Rating: 4

In compliance with SEBI rules, Narayana Hrudayalaya Limited is closing its trading window for insiders starting April 1, 2026. This closure is tied to the upcoming announcement of the company's audited financial results for the fiscal year ending March 31, 2026.

21st Mar 26

Impact Rating: 6

Narayana Health will conduct a physical group meeting with numerous analysts and institutional investors on Monday, March 23, 2026, from 10 AM to 5 PM IST, aiming to update them on business developments.

Peer Comparision

S.No.	Name	Current Price (Rs.)	Price to Earning	Market Capitalization (Rs.Cr.)	Dividend yield (%)	Net Profit latest quarter (Rs.Cr.)	YOY Quarterly profit growth (%)	Sales latest quarter (Rs.Cr.)	YOY Quarterly sales growth (%)	Return on capital employed (%)	Sales (Rs.Cr.)	OPM (%)	Profit after tax (Rs.Cr.)	Profit after tax latest quarter (Rs.Cr.)	Price to book value	Return on assets (%)	Debt to equity
1.	Apollo Hospitals	7448.45	64.06	107099.47	0.26	494.00	25.98	6303.50	12.78	16.64	23264.70	14.29	1671.90	477.20	11.78	7.77	0.88
2.	Max Healthcare	1036.45	71.57	100841.94	0.14	491.30	74.34	2135.47	25.07	14.88	7941.09	26.56	1409.01	491.30	10.03	8.32	0.33
3.	Fortis Health.	940.55	70.46	70973.78	0.11	328.82	40.23	2331.44	17.25	11.96	8433.62	22.03	1007.34	304.11	7.53	6.67	0.34
4.	Narayana Hrudaya	1921.00	84.51	39251.64	0.23	137.88	30.65	1019.17	9.08	19.45	3746.38	19.77	464.45	137.88	16.92	10.58	0.69
5.	Global Health	1237.25	55.54	33210.77	0.04	158.40	21.09	1099.22	14.91	19.74	4004.75	23.87	597.87	158.44	8.97	11.46	0.25
6.	Aster DM Health.	619.55	87.39	32077.12	0.81	121.31	13.83	1197.21	10.20	10.68	4325.23	18.61	367.05	110.24	7.08	2.44	0.46
7.	Krishna Institu.	626.00	76.17	25036.76	0.00	72.00	-37.45	960.70	23.59	15.00	3401.60	22.98	328.68	67.18	11.03	8.32	1.40
–	Median: 28 Co.	475.12	53.95	5171.9	0.0	33.23	20.55	333.23	15.08	15.0	1257.97	19.45	105.7	29.83	6.08	7.79	0.34

Quarterly Results

Standalone figures in ₹ crores

	Dec 2022	Dec 2023	Dec 2024	Jun 2023	Jun 2024	Jun 2025	Mar 2023	Mar 2024	Mar 2025	Sep 2022	Sep 2023	Sep 2024	Sep 2025
Sales	738	771	865	797	872	943	785	846	919	747	852	934	1,019
Expenses	606	633	708	659	715	764	665	690	743	621	688	752	790
Operating Profit	131	138	157	138	157	179	119	156	176	125	164	183	229
Other Income	9	11	9	9	14	16	60	89	107	27	14	13	17
Profit before tax	90	95	101	96	110	117	127	187	211	112	126	134	171
Tax %	35%	17%	22%	18%	22%	26%	28%	15%	24%	35%	13%	21%	20%
Net Profit	58	79	79	79	86	87	92	158	160	73	109	106	138
EPS in Rs	2.86	3.85	3.88	3.86	4.23	4.28	4.50	7.74	7.83	3.56	5.33	5.16	6.75

Profit & Loss

Standalone Figures in ₹ Crores / Yearly

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	1,076	1,308	1,470	1,646	1,848	2,077	2,239	1,655	2,412	2,965	3,266	3,590	3,746
Expenses	960	1,182	1,295	1,427	1,664	1,881	1,971	1,676	2,146	2,471	2,656	2,905	3,006
Operating Profit	115	126	175	219	184	196	268	-21	266	494	609	685	740
Other Income	25	10	2	14	16	17	19	71	104	95	120	139	149
Interest	29	38	23	17	26	43	55	48	45	55	65	98	106
Depreciation	55	64	67	68	78	91	128	123	119	139	161	169	182
Profit before tax	56	34	86	147	95	79	104	-121	206	395	503	557	601
Net Profit	36	21	57	95	58	50	68	-79	134	266	425	431	464
EPS in Rs	1,107.25	1.05	2.77	4.65	2.86	2.45	3.31	-3.85	6.54	13.00	20.77	21.10	22.74
Dividend Payout %	0%	0%	0%	0%	0%	41%	30%	0%	15%	19%	19%	21%	–

Balance Sheet

Standalone figures in ₹ crores

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Sep 2025
Equity Capital	0.33	200	204	204	204	204	204	204	204	204	204	204	204
Reserves	569	595	753	854	916	963	962	885	1,021	1,264	1,636	1,981	2,115
Borrowings	321	289	152	120	491	499	607	551	533	644	1,011	1,595	1,598
Other Liabilities	237	216	274	309	383	410	449	462	528	664	645	722	785
Total Liabilities	1,128	1,300	1,383	1,487	1,995	2,077	2,222	2,103	2,285	2,777	3,496	4,502	4,703
Fixed Assets	626	651	650	682	973	949	1,159	1,070	1,094	1,358	1,480	2,325	2,367
Gross Block	846	924	968	1,067	1,433	1,493	1,819	1,840	1,954	2,314	2,559	3,479	–
Accumulated Depreciation	220	273	318	385	461	544	660	770	861	956	1,079	1,153	–
CWIP	12	9	13	52	30	56	3	5	23	32	34	43	95
Investments	51	241	334	354	561	597	619	645	661	678	1,021	1,166	1,471
Other Assets	438	399	386	399	431	475	441	382	507	709	962	967	770
Total Assets	1,128	1,300	1,383	1,487	1,995	2,077	2,222	2,103	2,285	2,777	3,496	4,502	4,703

Cash Flows

Standalone Figures in ₹ Crores / Yearly

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	164	61	177	218	196	208	286	123	246	516	542	523
Cash from Investing Activity	-172	-192	-130	-162	-446	-137	-129	-12	-117	-621	-761	-755
Cash from Financing Activity	5	127	-2	-32	226	-11	-170	-114	-57	65	237	391
Net Cash Flow	-3	-4	46	25	-24	61	-12	-3	72	-40	19	159

Ratios

Standalone Figures in ₹ Crores / Yearly

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Debtor Days	45	40	34	31	37	28	24	34	26	22	21	25
Inventory Days	63	55	46	42	41	36	24	19	18	17	28	20
Days Payable	206	136	142	161	179	165	171	237	177	211	192	168
Cash Conversion Cycle	-98	-41	-62	-88	-102	-101	-124	-184	-133	-172	-143	-122
Working Capital Days	-30	-20	-6	-2	-10	-15	-26	-53	-36	-40	-39	-33
ROCE %	9%	7%	11%	15%	9%	8%	9%	-4%	15%	23%	23%	19%

Shareholding Pattern

Numbers in percentages

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Promoters	63.85%	63.85%	63.85%	63.85%	63.85%	63.85%	63.85%	63.85%	63.85%	63.85%	63.85%	63.85%
FIIs	10.24%	10.36%	11.10%	11.59%	11.51%	10.91%	10.01%	9.69%	9.45%	9.66%	10.46%	10.49%
DIIs	14.58%	14.14%	11.95%	10.89%	10.23%	9.51%	8.22%	7.90%	8.68%	8.52%	8.09%	7.76%
Public	10.70%	11.01%	12.45%	13.05%	13.78%	15.12%	17.29%	17.94%	17.39%	17.34%	16.98%	17.29%